Drawing for EMERY GLIDE

USPTO serial 79268811

EMERY GLIDE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
COLLOPY, DIANE PATRICIA
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EMERY GLIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations; products for medical or veterinary use, not included in other classes; chemical-pharmaceutical preparations and other preparations for medical or veterinary purposes, not included in other classes; adjuvants for medical purposes; chemical reagents for medical or veterinary purposes; radiological contrast substances for medical or veterinary purposes; radiological contrast substances for medical diagnostics for imaging structures and functions of cloth or organs in the human or animal body; diagnostic preparations for medical purposes; radiological contrast substances for assessment of human or animal organs and morbid [changes or organs]; radiological contrast substances for magnet resonance imaging (MRT, MR, MRI); radiological or MRI contrast substances for medical purposes; paramagnetic contrast substances; ferrofluids as contrast substances for medical or veterinary purposes; biodegradable contrast substances for medical or veterinary purposes; fluids based on hemins; fluids based on paramagnetic nanodots for medical or veterinary purposes; in-vitro diagnostics for medical purposes; in-vivo diagnostics for medical purposes; markers for medical or veterinary auxiliariesACTIVE—
010Surgical, medical and veterinary apparatus and instruments; medical apparatus and instruments; apparatus for use in medical and veterinary analysis; surgical implants of artificial materials, including catheters, stents, drains and surgical pulling wire; medical guidewiresACTIVE—
044Medical and veterinary services; medical support for human beings and animals, provided by persons or companies; medical analysis of imaging in connection with magnet resonance imaging and radiological diagnostics (including MRI scans); pharmaceutical advisory services; surgical services; medical and veterinary services in connection with endovascular, neurologic applications and internal drainsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 23, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 28, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 7, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 5, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 21, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 3, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 3, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 5, 2020MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 5, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 14, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 23, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 23, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 6, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019DOCKASSIGNED TO EXAMINER—
Oct 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance